Literature DB >> 16575531

Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus.

Charlotte Ryan1, Viateslav Zaitsev, David J Tindal, Jeffrey C Dyason, Robin J Thomson, Irina Alymova, Allen Portner, Mark von Itzstein, Garry Taylor.   

Abstract

Viruses of the Paramyxoviridae family are the leading cause of respiratory disease in children. The human parainfluenza viruses (hPIV) are members of the Paramyxovirinae subfamily, which also includes mumps virus, Newcastle disease virus (NDV), Sendai virus (SV) and simian type 5 virus (SV5). On the surface of these viruses is the glycoprotein hemagglutinin-neuraminidase (HN), which is responsible for cell attachment, promotion of fusion and release of progeny virions. This multifunctional nature of HN makes it an attractive target for the development of inhibitors as a treatment for childhood respiratory diseases. Here we report the crystal structure of NDV HN in complex with a derivative of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid, Neu5Ac2en, that has a functional group designed to occupy a large conserved binding pocket around the active site. The purpose of this study was to examine the effect of a bulky hydrophobic group at the O4 position of Neu5Ac2en, given the hydrophobic nature of the binding pocket. This derivative, with a benzyl group added to the O4 position of Neu5Ac2en, has an IC(50) of approximately 10 microM in a neuraminidase assay against hPIV3 HN. The IC(50) value of the parent compound, Neu5Ac2en, in the same assay is approximately 25 microM. These results highlight the striking difference between the influenza neuraminidase and paramyxovirus HN active sites, and provide a platform for the development of improved HN inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575531     DOI: 10.1007/s10719-006-5446-8

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  20 in total

1.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.

Authors:  S Crennell; T Takimoto; A Portner; G Taylor
Journal:  Nat Struct Biol       Date:  2000-11

2.  Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion.

Authors:  Helen Connaris; Toru Takimoto; Rupert Russell; Susan Crennell; Ibrahim Moustafa; Allen Portner; Garry Taylor
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion.

Authors:  Toru Takimoto; Garry L Taylor; Helen C Connaris; Susan J Crennell; Allen Portner
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

5.  Giant-cell pneumonia caused by parainfluenza virus.

Authors:  G Delage; P Brochu; M Pelletier; G Jasmin; N Lapointe
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

Review 6.  Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.

Authors:  K McIntosh; J M Fishaut
Journal:  Prog Med Virol       Date:  1980

7.  Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.

Authors:  Ping Yuan; Thomas B Thompson; Beth A Wurzburg; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Structure       Date:  2005-05       Impact factor: 5.006

8.  Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.

Authors:  Irina V Alymova; Garry Taylor; Toru Takimoto; Tsu-Hsing Lin; Pooran Chand; Y Sudhakara Babu; Chenghong Li; Xiaoping Xiong; Allen Portner
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Fusion deficiency induced by mutations at the dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is due to a temperature-dependent defect in receptor binding.

Authors:  Elizabeth A Corey; Anne M Mirza; Elizabeth Levandowsky; Ronald M Iorio
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses.

Authors:  X L Hu; R Ray; R W Compans
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  7 in total

1.  The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.

Authors:  Matteo Porotto; Zuhair Salah; Ilaria DeVito; Aparna Talekar; Samantha G Palmer; Rui Xu; Ian A Wilson; Anne Moscona
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

2.  Fixation of oligosaccharides to a surface may increase the susceptibility to human parainfluenza virus 1, 2, or 3 hemagglutinin-neuraminidase.

Authors:  Mary M Tappert; David F Smith; Gillian M Air
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

3.  Synthesis and chemical characterization of several perfluorinated sialic acid glycals and evaluation of their in vitro antiviral activity against Newcastle disease virus.

Authors:  P Rota; N Papini; P La Rocca; M Montefiori; F Cirillo; M Piccoli; R Scurati; L Olsen; P Allevi; L Anastasia
Journal:  Medchemcomm       Date:  2017-06-05       Impact factor: 3.597

4.  Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus.

Authors:  Benhur Lee; Olivier Pernet; Asim A Ahmed; Antra Zeltina; Shannon M Beaty; Thomas A Bowden
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

5.  New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2.

Authors:  Kai Xu; Yee-Peng Chan; Kanagalaghatta R Rajashankar; Dimple Khetawat; Lianying Yan; Momchil V Kolev; Christopher C Broder; Dimitar B Nikolov
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

6.  Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt.

Authors:  Ibrahim Moharam; Olayinka Asala; Sven Reiche; Hafez Hafez; Martin Beer; Timm Harder; Christian Grund
Journal:  Virol J       Date:  2021-04-26       Impact factor: 4.099

7.  Optimization of a direct spectrophotometric method to investigate the kinetics and inhibition of sialidases.

Authors:  Jasvinder Kaur Hayre; Guogang Xu; Luisa Borgianni; Garry L Taylor; Peter W Andrew; Jean-Denis Docquier; Marco R Oggioni
Journal:  BMC Biochem       Date:  2012-10-02       Impact factor: 4.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.